COSTEM Congress

Do we need allogeneic HSCT consolidation after CD19 CAR T therapy for pediatric ALL? – COSTEM Congress

COSTEM Congress posted on X:

“Do we need allogeneic HSCT consolidation after CD19 CAR T therapy for pediatric ALL?

We are excited to welcome a debate by Peihua Lu and André Baruchel!

Click to register.”